Sangkum Premsant, Sirisopana Kun, Matang Wijittra, Phengsalae Yada, Lertsithichai Panuwat, Ketsuwan Chinnakhet, Kochakarn Wachira, Kongchareonsombat Wisoot
Division of Urology, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University.
Division of Breast and Endocrine, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University.
Sex Med. 2021 Dec;9(6):100453. doi: 10.1016/j.esxm.2021.100453. Epub 2021 Oct 26.
Phosphodiesterase 5 inhibitors are the predominant treatment option for erectile dysfunction.
This study evaluates the efficacy and safety of sildenafil orally disintegrating strips for the treatment of erectile dysfunction.
One hundred twenty erectile dysfunction patients were enrolled in a prospective, randomized, controlled crossover study and allocated into 2 groups of 60 participants. Patients were either treated with sildenafil strips or tablets for 8 weeks after which they crossed over into the alternate treatment formulation for another 8 weeks following a 4-week wash-out period. Each participant was assessed 8 times throughout the study period and their formulation preference registered at the end of the study.
Changes in the abridged International Index of Erectile Function (IIEF-5) score and Erection Hardness Score (EHS) resulting from sildenafil orally disintegrating strip or tablet treatments were the primary end points, with differences in onset of action, duration of action, and incidence of adverse events between the 2 formulations included as secondary end points.
Both sildenafil formulations were effective in treating patients with erectile dysfunction. There was significant improvement of erectile function in term of IIEF-5 score and EHS from both formulations. The number and type of adverse events were also comparable. Likewise, there were no statistically significant differences between the earliest onset of action times and longest duration of action times. However, the results showed a 7.1-minute earlier onset of action time for orally disintegrating strips that may be considered as clinically meaningful by some patients.
Sildenafil orally disintegrating strips are a safe and effective alternative to the conventional tablet formulation for the treatment of erectile dysfunction. Sangkum P, Sirisopana K, Matang W, et al. Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial. Sex Med 2021;9:100453.
磷酸二酯酶5抑制剂是勃起功能障碍的主要治疗选择。
本研究评估西地那非口腔崩解片治疗勃起功能障碍的疗效和安全性。
120例勃起功能障碍患者参与了一项前瞻性、随机、对照交叉研究,分为两组,每组60人。患者分别接受西地那非片或口腔崩解片治疗8周,在4周的洗脱期后,交叉接受另一种治疗剂型治疗8周。在整个研究期间,每位参与者接受8次评估,并在研究结束时记录他们对剂型的偏好。
西地那非口腔崩解片或片剂治疗后,简化国际勃起功能指数(IIEF-5)评分和勃起硬度评分(EHS)的变化是主要终点,两种剂型在起效时间、作用持续时间和不良事件发生率方面的差异作为次要终点。
两种西地那非剂型均能有效治疗勃起功能障碍患者。两种剂型在IIEF-5评分和EHS方面均使勃起功能有显著改善。不良事件的数量和类型也相当。同样,最早起效时间和最长作用时间之间也没有统计学上的显著差异。然而,结果显示口腔崩解片的起效时间早7.1分钟,一些患者可能认为这具有临床意义。
西地那非口腔崩解片是治疗勃起功能障碍的一种安全有效的替代传统片剂剂型的药物。桑库姆P、西里索帕纳K、马唐W等。口腔崩解片西地那非治疗勃起功能障碍的疗效:一项前瞻性随机试验。性医学2021;9:100453。